This post is from our archives and not all features will display correctly.
Ford government’s delay to enact drug policy costing Ontario: lobby group
The Government of Ontario has been working on a biosimilars-switching plan since before COVID-19.
Published Oct 11, 2022 at 4:58pm
Read this for free.
Log in below to get access to this article. One free per week.